Skip to main content

Mitochondrial Medicine Program News

Our team of world-renowned experts are focused on determining the best course of treatment for each patient while working with your primary care physician, neurologist and other specialists.

Appointments and referrals

Gene Therapy for Hemophilia: Are We There Yet?

Oct 31, 2016

Recent gene therapy trial for hemophilia B showed promising results, with patients’ average factor IX level of 32 percent after treatment. CHOP aims to open a hemophilia A gene therapy trial modeled after the hemophilia B trial.

The Scoop on Infant Poop: Is That Normal?

Jul 10, 2023

When parenting your first baby, everything is new and a potential cause for worry so let CHOP pediatrician Joseph Gwiszcz, MD, FAAP, give you the scoop on baby poop.

Jump back to top